This paper is published in Volume-6, Issue-3, 2020
Area
InformationTechnology
Author
Roshani R. Zamare, Shital P. Dhok, Sampada V. Babhulkar, Richa S. Singh, Jayshri G. Marbade, Nayan D. Bawane, Abhishek M. Shukla
Org/Univ
DMIETR - Datta Meghe Institute of Engineering, Technology and Research, Wardha, Maharashtra, India
Pub. Date
25 June, 2020
Paper ID
V6I3-1621
Publisher
Keywords
Alternate, Medicine, Recommendation

Citationsacebook

IEEE
Roshani R. Zamare, Shital P. Dhok, Sampada V. Babhulkar, Richa S. Singh, Jayshri G. Marbade, Nayan D. Bawane, Abhishek M. Shukla. Alternate Medicine Recommendation, International Journal of Advance Research, Ideas and Innovations in Technology, www.IJARIIT.com.

APA
Roshani R. Zamare, Shital P. Dhok, Sampada V. Babhulkar, Richa S. Singh, Jayshri G. Marbade, Nayan D. Bawane, Abhishek M. Shukla (2020). Alternate Medicine Recommendation. International Journal of Advance Research, Ideas and Innovations in Technology, 6(3) www.IJARIIT.com.

MLA
Roshani R. Zamare, Shital P. Dhok, Sampada V. Babhulkar, Richa S. Singh, Jayshri G. Marbade, Nayan D. Bawane, Abhishek M. Shukla. "Alternate Medicine Recommendation." International Journal of Advance Research, Ideas and Innovations in Technology 6.3 (2020). www.IJARIIT.com.

Abstract

On the Internet, where the number of choices is overwhelming, there is a need to filter, prioritize and efficiently deliver relevant information to alleviate the problem of information overload, which has created a potential problem for many Internet users. Alternate Medicine System solves this problem by searching through a large volume of medical information to provide users with filters and services. This project explores the different characteristics and potentials of different recommendation techniques in recommendation systems to serve as a compass for research and practice in the field of medical recommendation systems. In this project, we have used a dataset over 100+ medicines from different companies and brands to do recommendation based on the content of medicine and then filter it based on rating and cost-based analysis. Through experimental results, we have found that more than 95% of the medicines have a lower cost based alternative available with a higher rating.